Abstract
In developing countries, renal transplantation is offered to young end-stage renal disease (ESRD) patients, while the older ones face limitations due to higher mortality risk. We retrospectively analyzed 225 patients who underwent renal transplantation from living donors, aged 40–60 years (Group A) and >60 years (Group B), focusing on their survival outcome. Group A (n = 181) had mean creatinine (mg/dL) 1.41 ± 0.84, 1.30 ± 0.65 and 1.40 ± 0.60 and mean eGFR (mL/min/1.73 m2) of 65.32 ± 23.03, 69.14 ± 32.65 and 59.21 ± 22.79 at 0, 3 and 6 months post-transplantation. Death-censored graft survival was 93.1% in first year followed by 91.2% in subsequent 4 years. Patient survival was 92.5% in first year, 90.7% in the next 2 years, and 89.2% in 4th year. Highest cumulative graft survival was 86.7% in the first year with 83.4%, 82.7% and 82.4% during the subsequent 3 years. Group B (n = 44) had mean creatinine (mg/dL) of 1.46 ± 1.02, 1.29 ± 0.23 and 1.2 ± 0.29 with a mean eGFR (mL/min/1.73 m2) of 67.90 ± 23.48, 67.02 ± 12.76 and 75.23 ± 15.19 at 0, 3 and 6 months. Highest death-censored graft survival was 97.4% in the first year with 94.7% in next 3 years. Patient survival was 88.1% throughout 4 years post-transplantation. Cumulative graft survival was 84.1% during 4 years. Biopsy-proven acute rejection rate was 28.7% in group A and 15.9% in group B (P = 0.058). There was higher mortality rate in group B with death mainly due to infections and cardiovascular complication. Cardiovascular risk assessment, pre-transplant cancer screening and judicious use of immunosuppressive agents should help minimize adverse events, balanced with an inherently reduced risk of acute rejection, hence the graft survival advantage and is the way forward to maximize patient and renal allograft survival in elderly patients.
Similar content being viewed by others
References
US Renal Data Systems (2002) USRDS 2002 Annual data report: atlas of end-stage renal disease in the United States. National Institute of Health, National Institute of Diabetes and Kidney Disease, Bethesda
Cameron JI, Whiteside C et al (2000) Difference in quality of life across renal replacement therapies: a meta-analysis comparison. Am J Kidney Dis 35:629–637
Helderman JH (1995) Transplantation in the elderly. Nephrol Dial Transplant 10:773–774
Nankivell BJ, Gruenewald SM, Allen RD et al (1995) Predicting glomerular filtration rate after kidney transplantation. Transplantation 59:1683
U.S. Census Bureau International database. Table 094. Midyear population, by age and sex. Available http://www.census.gov/populaiton/www/projections/natdetD1A.html
Wolfe RA, Ashby VB et al (1999) Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341:1725–1730
Oniscu GC, Brown H et al (2005) Impact of cadaveric renal transplantation on survival in patient listed for transplantation. J Am Soc Nephrol 16:1859–1865
US Renal Data System (2008) USRDS 2008 annual data report: atlas of end-stage renal disease in the United States. National Institute of Health, National Institute of Diabetes and Digestive and Kidney Disease, Bethesda
Johnson DW, Herzig K et al (2000) A comparison of the effects of dialysis and renal transplantation on the survival of older uremic patients. Transplantation 69:794–799
Male and female life expectancy. United Nations Population Division. 2009
Bonal J, Cleris M et al (1997) Renal registry committee. Transplantation versus haemodialysis in elderly patients. Nephrol Dial Transplant 12:261–264
Meier-Kriesche HU, Ojo A et al (2008) Increased immunosuppressive vulnerability in elderly renal transplant recipients. Transplantation 69:885–889
Wu C, Shapiro R et al (2008) Kidney transplantation in elderly people: the influence of recipient comorbidity and living kidney donors. J Am Geriatr Soc 56:231–238
Meier-Kreiesche HU, Srinivas TR et al (2001) Interaction between acute rejection and recipient age on long-term renal allograft survival. Transplant Proc 33:3425–3426
Ojo AO, Hanson JA et al (2000) Long-term survival in renal transplant recipients with graft function. Kidney Int 57:307–313
Cossarizza A, Ortolani C et al. Cytometric analysis of immunosenescence. Cytometry 27:297–313
Effros RB Costimulatory mechanisms in the elderly. Caccine 18:1661–1665
Vierboom MP, Oseevoort M, Sick EA et al. Induction of allograft tolerance through costimulatory blockade: first selection of drugs in vitro. Transpl Immunol 11:215–222
Fernandez-Gutierrez B, Jover JA et al. Early lymphocyte activation in elderly humans: impaired T and T-dependant B-cell responses. Exp Gerontol 34:217–229
Saxena R, Yu X et al (2009) Renal transplantation in the elderly. Int Urol Nephrol 41:192–210
Lindholm A, Albrechtson D et al (1995) Ischaemic heart disease-major cause of death and graft loss after renal transplantation in Scandinavia. Transplantation 60(5):451–457
Cole EH, Farewell VT, Aprile M et al (1995) Renal transplantation in older patients: the University of Toronto experience. Geriatr Nephrol Urol 5:85–92
Mohamed Ali AA, Abraham G, Mathew M et al (2009) Can serial eGFR, body mass index and smoking predict renal allograft survival in south Asian patients. Saudi J Kidney Dis Transpl 20(6):984–990
Edmund Huang, Doory L.Segev, Hamid Rabb. Kideny transplantation in the elderly. Seminars in nephrology
Cardella CJ, Harding ME, Abraham G, Robinson C et al (1989) Renal transplantation in older patients on peritoneal dialysis. Tranplant Proc 21:2022–2023
Velez RL, Brinker KR, Vergne-Marinin PJ et al (1991) Renal transplantation with cyclosporine in the elderly population. Transplnat Proc 23:1749–1752
Miller RA (1989) The cell biology of aging: immunological model. J Gerontol 44:B4–B8
Ringden O, Ost L, Klintmalm G et al (1983) Improved outcome in renal transplant recipients above 55 years of age treated with cyclosporine and low dose steroids. Transplant Proc 15:S2507–S2512
Fox RA (1985) Immunology of aging. In: Brocklehurst JC (ed) Textbook of geriatric medicine and gerontology. Churchill livingstone, New York, pp 82–104
John GT, Shankar V, Abraham AM, Mukundan U et al (2001) Risk factors for post-transplant tuberculosis. Kidney Int 60:1148–1153
Laupacis A, Keown P, Pus N, Kruger H et al (1996) A study of the quality of life and cost-utility of renal transplantation. Kidney Int 50:235–242
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mohamed Ali, A.A., Abraham, G., Khanna, P. et al. Renal transplantation in the elderly: South Indian experience. Int Urol Nephrol 43, 265–271 (2011). https://doi.org/10.1007/s11255-010-9887-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-010-9887-4